This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ardea Biosciences, Inc. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: Suetying Chow: Innovator in Cancer Treatment
Introduction
Suetying Chow is a notable inventor based in Irvine, CA, who has made significant contributions to the field of cancer treatment. With a focus on developing innovative compounds, Chow has been instrumental in advancing medical research and therapeutic options.
Latest Patents
Chow holds 2 patents related to his work on pyridone sulfonamides and pyridone sulfamides as MEK inhibitors. These inventions involve N-(ortho phenylamino dihydropyridyl)sulfonamides and N-(ortho phenylamino dihydropyridyl), N'-alkyl sulfamides, which serve as inhibitors of MEK. They are particularly useful in the treatment of cancer and other hyperproliferative diseases.
Career Highlights
Chow is currently associated with Ardea Biosciences, Inc., where he continues to push the boundaries of medical innovation. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Chow collaborates with esteemed colleagues, including Shunqi Yan and Jean-Michel Andre Vernier, to further enhance the research and development of effective treatments.
Conclusion
Suetying Chow's contributions to the field of cancer treatment through his innovative patents highlight his role as a key figure in medical research. His ongoing work promises to make a significant difference in the lives of patients facing challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile